Delivery Order SPE2DB24D8002-SPE2DB25FJNZC
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $2,418.92 and an ultimate completion date of June 11, 2025. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $3,243.48 contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, with a completion date of June 17, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the...
- This is a $1,206.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the provision of Fluticasone-Salmeterol 100-50 60s, a respiratory medication, with a period of performance through July 2, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, which has a ceiling value of $10,491.73 and a completion date of May 20, 2025, is for the supply of Fluticasone-Salmeterol 250-50 60s, a respiratory medication. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies,...
- This is a $1,479.28 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of FLUTICASONE-SALMETEROL 115-21 12GM, a respiratory medication, with a period of performance through June 12, 2025. Dakota Drug, Inc. also holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,830.16, is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) vehicle with a ceiling value of...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $2,648.46 and a completion date of May 28, 2025. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $9,035.88 and a period of performance through March 3, 2025. The contract is not set aside. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
- This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $6,172.15 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to the DLA. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,128.03 contract is for the delivery of Fluticasone-Salmeterol 500-50 60s, a pharmaceutical product used to treat respiratory conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with DLA Troop Support Medical's ECAT...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJNZCDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication, with a ceiling value of $1,158.34 and an ultimate completion date of June 27, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC), identified as SPE2DB24D8001, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This contract, valued at $999,999,999.00, allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract originated from DLA Troop Support Medical's solicitation SPE2DH-21-R-0002, which sought proposals for commercial medical equipment, accessories, consumables, and medical simulation equipment used by medical professionals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/26/25 |